Linnaeus Therapeutics
Michael is one of the directors. He is the Director of PCI Ventures at Penn, and he has been with Linnaeus since the beginning. He leads his team in the development of entrepreneurial ventures for the Penn community through several accelerator programs such as Upstart, UPadvisors, AppitUP and DevelUPmed.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Linnaeus Therapeutics
Linnaeus Therapeutics, Inc. is a privately-held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that target G protein-coupled receptors.